The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Ganciclovir
Abstract
Ganciclovir is a nucleoside analogue of guanosine, a homologue of acyclovir, and the first antiviral drug to be effective in the treatment of cytomegalovirus (CMV) disease in humans.14 It inhibits not only all the herpesviruses but also the transformation of normal cord-blood lymphocytes by Epstein–Barr virus.57 In this review, I outline ganciclovir's mechanisms of action and resistance and discuss the clinical effectiveness of intravenous and oral ganciclovir.Mechanism of ActionThe structures of ganciclovir and of its analogue acyclovir are shown in Figure 1. In vivo, ganciclovir is converted to ganciclovir triphosphate, which inhibits viral DNA polymerases, including those . . .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schmidt, G. M., Horak, D. A., Niland, J. C., Duncan, S. R., Forman, S. J., Zaia, J. A., & the City of Hope–Stanford–Syntex CMV Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199104113241501 · Cited by 616
Goodrich, J. M., Mori, M., Gleaves, C. A., Du Mond, C., Cays, M., Ebeling, D. F., Buhles, W. C., DeArmond, B., & Meyers, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252303 · Cited by 599
Reed, E. C., Bowden, R. A., Dandliker, P. S., Lilleby, K. E., & Meyers, J. D. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-10-783 · Cited by 548
Emanuel, D., Cunningham, I., Jules-Elysee, K., Brochstein, J. A., Kernan, N. A., Laver, J., Stover, D., White, D. A., Fels, A., Polsky, B., et al. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-10-777 · Cited by 490
(1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260401 · Cited by 487
Sullivan, V., Talarico, C. L., Stanat, S. C., Davis, M., Coen, D. M., & Biron, K. K. (1992) · Nature · doi:10.1038/358162a0 · Cited by 471
Collaborative DHPG Treatment Study Group (1986) · New England Journal of Medicine · doi:10.1056/nejm198603273141301 · Cited by 427
Littler, E., Stuart, A. D., & Chee, M. S. (1992) · Nature · doi:10.1038/358160a0 · Cited by 386
Cytomegalovirus Retinitis and Acquired Immunodeficiency Syndrome
Jabs, D. A. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070010077031 · Cited by 379
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376
9-(1,3-Dihydroxy-2-propoxymethyl)guanine: a new potent and selective antiherpes agent
Martin, J. C., Dvorak, C. A., Smee, D. F., Matthews, T. R., & Verheyden, J. P. H. (1983) · Journal of Medicinal Chemistry · doi:10.1021/jm00359a023 · Cited by 341
Martin, D. F. (1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090240037023 · Cited by 338
Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Persons with AIDS
Spector, S. A., McKinley, G. F., Lalezari, J. P., Samo, T., Andruczk, R., Follansbee, S., Sparti, P. D., Havlir, D. V., Simpson, G., Buhles, W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606063342302 · Cited by 308
Winston, D. J., Wirin, D., Shaked, A., & Busuttil, R. W. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92110-9 · Cited by 261
Hibberd, P. L., Tolkoff-Rubin, N. E., Conti, D., Stuart, F., Thistlethwaite, J. R., Neylan, J. F., Snydman, D. R., Freeman, R., Lorber, M. I., & Rubin, R. H. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-1-199507010-00002 · Cited by 256
Cheng, Y. C., Huang, E. S., Lin, J. C., Mar, E. C., Pagano, J. S., Dutschman, G. E., & Grill, S. P. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.9.2767 · Cited by 253
Biron, K. K., Stanat, S. C., Sorrell, J. B., Fyfe, J. A., Keller, P. M., Lambe, C. U., & Nelson, D. J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.8.2473 · Cited by 236
Mechanism of action of foscarnet against viral polymerases
Crumpacker, C. S. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90329-a · Cited by 203
Self-citationBuhles, W. C., Mastre, R. J., Tinker, A. J., Strand, V., Koretz, S. H., & Koretz, S. H. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.supplement_3.s495 · Cited by 197
Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxyguanosine (2′NDG)
Ashton, W. T., Karkas, J. D., Field, A. K., & Tolman, R. L. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(82)80109-5 · Cited by 189
Alpha-, Beta- and Gammaherpesviruses Encode a Putative Phosphotransferase
Chee, M. S., Lawrence, G. L., & Barrell, B. G. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-5-1151 · Cited by 174
Cheng, Y., Grill, S. P., Dutschman, G. E., et al. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44198-6 · Cited by 156
Phosphotransferase sequence homology
Brenner, S. (1987) · Nature · doi:10.1038/329021a0 · Cited by 155
Long-term Intravitreal Ganciclovir Therapy for Cytomegalovirus Retinopathy
Heinemann, M. H. (1989) · Archives of Ophthalmology · doi:10.1001/archopht.1989.01070020849025 · Cited by 147
Dieterich, D. T., Kotler, D. P., Busch, D. F., Crumpacker, C. S., Mond, C. D., Dearmand, B., & Buhles, W. C. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.2.278 · Cited by 142
Self-citationGanciclovir in the treatment of progressive AIDS‐related polyradiculopathy
Miller, R. G., Storey, J. R., & Greco, C. (1990) · Neurology · doi:10.1212/wnl.40.4.569 · Cited by 138
Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir
Lurain, N. S., Spafford, L. E., & Thompson, K. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4427-4431.1994 · Cited by 137
Toxicity of Combined Ganciclovir and Zidovudine for Cytomegalovirus Disease Associated with AIDS
Höchster, H. S., Dieterich, D. T., Bozzette, S. A., Reichman, R. C., Connor, J. D., Liebes, L., Sonke, R. L., Spector, S. A., Valentine, F. T., Pettinelli, C., et al. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-2-111 · Cited by 130
Wolf, D. G., & Spector, S. A. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.6.1412 · Cited by 126
Failure of Antiviral Therapy for Acquired Immunodeficiency Syndrome-Related Cytomegalovirus Myelitis
Jacobson, M. Z., MILLS, J. S., Rush, J. D., et al. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520340044009 · Cited by 37
REGRESSION OF CAUDA EQUINA SYNDROME IN AIDS PATIENT BEING TREATED WITH GANCICLOVIR
Graveleau, P., Pérol, R., & Chapman, A. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92129-6 · Cited by 19
Cited by
Antiviral Drug Resistance of Human Cytomegalovirus
Lurain, N. S., & Chou, S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00009-10 · Cited by 596
Comprehensive Review in Current Developments of Benzimidazole‐Based Medicinal Chemistry
Keri, R. S., Hiremathad, A., Budagumpi, S., & Nagaraja, B. M. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12462 · Cited by 394
Divergent Effects of Human Cytomegalovirus and Herpes Simplex Virus-1 on Cellular Metabolism
Vastag, L., Koyuncu, E., Grady, S. L., Shenk, T. E., & Rabinowitz, J. D. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002124 · Cited by 358
Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy
De Clercq, E., & Field, H. J. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706446 · Cited by 336
Balfour, H. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401608 · Cited by 285
Metadata
- Authors
- Crumpacker, C. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-09-05
- Volume
- 335
- Issue
- 10
- Pages
- 721-729
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4231692149
- Cited by
- 382
- References
- 33
- FWCI
- 22.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.